Deals

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs
Eli LillyHKG: 9969

InnoCare Strikes Strategic Research and Licensing Deal With Eli Lilly – Up to USD 100 Million Upfront and USD 3.25 Billion in Milestones for Up to Five Innovative Target Programs

InnoCare Pharma Limited (HKG: 9969; SHA: 688428) announced that it has entered into a strategic research, development, and licensing agreement with Eli Lilly and Company (NYSE: LLY) to develop innovative…

Sanyou Bio and NovoCodex Forge Strategic ADC Partnership – AI‑Driven Antibody Discovery Meets Site‑Specific Conjugation for Dual‑Targeting, Dual‑Payload Programs

Sanyou Bio and NovoCodex Forge Strategic ADC Partnership – AI‑Driven Antibody Discovery Meets Site‑Specific Conjugation for Dual‑Targeting, Dual‑Payload Programs

Shanghai RAAS to Acquire 100% of Boehringer Ingelheim China Investment Entity for Up to RMB 20 Million – Deal Secures End‑to‑End In‑House Control of First‑in‑Class SR604 Injection

Shanghai RAAS to Acquire 100% of Boehringer Ingelheim China Investment Entity for Up to RMB 20 Million – Deal Secures End‑to‑End In‑House Control of First‑in‑Class SR604 Injection

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Boehringer Ingelheim Licenses Spevigo to LEO Pharma for Global Dermatology Expansion
BiotechBoehringer Ingelheim

Boehringer Ingelheim Licenses Spevigo to LEO Pharma for Global Dermatology Expansion

Golden Age Health Secures Exclusive Rights to Innostellar's Gene Therapy LX-101 in China
Gene therapyGolden Age Health

Golden Age Health Secures Exclusive Rights to Innostellar’s Gene Therapy LX-101 in China

Mabwell Signs Licensing Agreement with Unilab for Denosumab Biosimilars in the Philippines
BiosimilarsMabwell Bioscience

Mabwell Signs Licensing Agreement with Unilab for Denosumab Biosimilars in the Philippines

Innovent Biologics and JD Health Form Strategic Partnership to Enhance Drug Supply and Healthcare Services
HKG: 1801HKG: 6618

Innovent Biologics and JD Health Form Strategic Partnership to Enhance Drug Supply and Healthcare Services

Show More